This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
A Study of TAR-200 Versus Intravesical Chemotherapy in Participants With Recurrent High-Risk Non-Muscle-Invasive Bladder Cancer (HR-NMIBC) After Bacillus Calmette-Guérin (BCG) | MicrobiomeTrials
← Back to trials NCT06211764
A Study of TAR-200 Versus Intravesical Chemotherapy in Participants With Recurrent High-Risk Non-Muscle-Invasive Bladder Cancer (HR-NMIBC) After Bacillus Calmette-Guérin (BCG) Recruiting PHASE3 INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2024-04-09Est. Completion: 2030-11-27
Enrollment target: 272 participantsLocations Arkansas Urology, Little Rock, Arkansas, United States Genesis Research LLC 1, Los Alamitos, California, United States USC Norris Comprehensive Cancer Center, Los Angeles, California, United States University of California Irvine Medical Center, Orange, California, United States University of California San Francisco, San Francisco, California, United States Genesis Research LLC, Torrance, California, United States Colorado Clinical Research, Lakewood, Colorado, United States Florida Urology Partners, Riverview, Florida, United States Northwestern University, Chicago, Illinois, United States UroPartners, Chicago Ridge, Illinois, United States Urology of Indiana, Carmel, Indiana, United States First Urology, PSC, Jeffersonville, Indiana, United States Wichita Urology Group, Wichita, Kansas, United States Comprehensive Urology, Royal Oak, Michigan, United States Specialty Clinical Research of St Louis, St Louis, Missouri, United States Associated Medical Professionals, Syracuse, New York, United States Other microbiome trials you might be interested in Urothelial Cancer Urinary Bladder Neoplasms
This study is being done to see how well two drugs (enfortumab vedotin and pembrolizumab) work together as a bladder pre…
Santa Barbara, United States Est. completion Mar 31, 2030
Muscle Invasive Bladder Urothelial Carcinoma Stage II Bladder Cancer AJCC v8 Stage IIIA Bladder Cancer AJCC v8
This phase II trial tests the effect of intravesical nadofaragene firadenovec in combination with gemcitabine, cisplatin…
Seattle, United States
The Urology Group, Cincinnati, Ohio, United States
Central Ohio Urology Group, Gahanna, Ohio, United States
Centers for Advanced Urology LLC d b a MidLantic Urology, Bala-Cynwyd, Pennsylvania, United States
Ralph H. Johnson Veterans Affairs Medical Center, Charleston, South Carolina, United States
Carolina Urologic Research Center, Myrtle Beach, South Carolina, United States
Low Country Urology Clinics, North Charleston, South Carolina, United States
Urology Associates, Nashville, Tennessee, United States
Vanderbilt University Medical Center, Nashville, Tennessee, United States
Urology Austin, Austin, Texas, United States
Urology Clinics of North Texas, Dallas, Texas, United States
University of Texas Southwestern Medical Center, Dallas, Texas, United States
Houston Metro Urology, Houston, Texas, United States
Spokane Urology, Spokane, Washington, United States
Clinica Santa Isabel, Buenos Aires, Argentina
Investigaciones Clinico Moleculares (ICM), CABA, Argentina
Cemaic Centro Privado de Especialidades Medicas Ambulatorias e Investigacion Clinica, Córdoba, Argentina
Centro Urologico Profesor Bengio, Córdoba, Argentina
Hospital Privado de la Comunidad, Mar del Plata, Argentina
AZ Sint-Jan, Bruges, Belgium
Cliniques Universitaires Saint Luc, Brussels, Belgium
Ziekenhuis Oost-Limburg, Genk, Belgium
Algemeen ziekenhuis Maria Middelares, Ghent, Belgium
Algemeen Ziekenhuis Delta, Roeselare, Belgium
Fundacao Pio XII, Barretos, Brazil
NAIC Nair Antunes Instituto do Cancer, Bauru, Brazil
Hospital das Clinicas da Universidade Estadual de Campinas UNICAMP, Campinas, Brazil
Liga Paranaense de Combate ao Cancer, Curitiba, Brazil
Irmandade Santa Casa de Misericordia de Porto Alegre, Porto Alegre, Brazil
Hospital da Bahia, Salvador, Brazil
Sociedade Beneficente de Senhoras Hospital Sirio Libanes, São Paulo, Brazil
Real e Benemérita Associação Portuguesa de Beneficência, São Paulo, Brazil
Fundacao Antonio Prudente A C Camargo Cancer Center, São Paulo, Brazil
Peking University First Hospital, Beijing, China
West China School of Medicine/West China Hospital, Sichuan University, Cheng Du Shi, China
Chongqing Cancer Hospital, Chongqing, China
Sun Yat Sen University Cancer Center, Guangzhou, China
Shengjing Hospital Of China Medical University, Shenyang, China
Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
The Second Hospital Of Tianjin Medical University, Tianjin, China
The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China
Tongji Medical College of Huazhong University Science Technology of Medicine Health Management, Wuhan, China
Xi an Jiaotong University Hospital, Xi'an, China
Hopital Claude Huriez, Lille, France
Polyclinique de Limoges - Francois Chenieux, Limoges, France
Institut Paoli Calmettes, Marseille, France
APHP - Hopital Bichat - Claude Bernard, Paris, France
Clinique de la Croix du Sud, Quint-Fonsegrives, France
Chu Rennes Hopital Pontchaillou, Rennes, France
Hopital Foch, Suresnes, France
Universitaetsklinikum Koeln, Cologne, Germany
Universitaetsklinikum Halle Saale, Halle, Germany
Klinikum Leverkusen gGmbH, Leverkusen, Germany
Universitatsklinikum Schleswig Holstein Campus Lubeck, Lübeck, Germany
Urologie Neandertal Praxis Mettmann, Mettmann, Germany
Klinikum der Universitaet Muenchen, München, Germany
Ospedale San Donato, Arezzo, Italy
San Raffaele Hospital, Milan, Italy
Istituto Dei Tumori Di Milano, Milan, Italy
Ospedale Provinciale di Macerata, Province of Macerata, Italy
Ospedale S. Maria Delle Croci, Ravenna, Italy
Universita Campus Bio-Medico di Roma, Roma, Italy
Istituto Nazionale Tumori Regina Elena, Roma, Italy
Istituto Clinico Humanitas, Rozzano, Italy
PO Molinette Azienda Ospedaliero Universitaria Citta della Salute e della Scienza di Torino, Torino, Italy
Funabashi Municipal Medical Center, Funabashi Shi, Japan
Hakodate Goryoukaku Hospital, Hakodate, Japan
Hyogo Prefectural Amagasaki General Medical Center, Hyōgo, Japan
Niigata Cancer Center Hospital, Niigata, Japan
National Hospital Organization Okayama Medical Center, Okayama, Japan
Toho University Sakura Medical Center, Sakura, Japan
Toranomon Hospital, Tokyo, Japan
Yokohama City University Medical Center, Yokohama, Japan
Uniwersytecki Szpital Kliniczny w Bialymstoku, Bialystok, Poland
IN VIVO Sp. z o.o, Bydgoszcz, Poland
Szpital Uniwersytecki w Krakowie, Krakow, Poland
Uniwersytecki Szpital Kliniczny nr 4, Lublin, Poland
Wojewodzki Szpital im Sw Ojca Pio w Przemyslu, Przemyśl, Poland
Szpital Wojewodzki im Sw Lukasza SP ZOZ, Tarnów, Poland
MICS Centrum Medyczne Torun, Torun, Poland
Mazowiecki Szpital Onkologiczny, Wieliszew, Poland
Dolnoslaskie Centrum Onkologii, Wroclaw, Poland
Centrul Medical Unirea SRL, Brasov, Romania
Ponderas Academic Hospital, Bucharest, Romania
Institutul Oncologic Ion Chiricuta, Cluj-Napoca, Romania
Regina Maria, Cluj-Napoca, Romania
Spitalul Clinic Judetean de Urgenta Pius Brinzeu, Timișoara, Romania
Chungbuk National University Hospital, Chungcheongbuk Do, South Korea
Keimyung University Dongsan Hospital, Daegu, South Korea
National Cancer Center, Gyeonggi-do, South Korea
Chonnam National University Hwasun Hospital, Jeollanam-do, South Korea
Seoul National University Hospital, Seoul, South Korea
Samsung Medical Center, Seoul, South Korea
The Catholic University of Korea Seoul St Mary s Hospital, Seoul, South Korea
Pusan National University Yangsan Hospital, Yangsan, South Korea
Hosp. Univ. Germans Trias I Pujol, Badalona, Spain
Fund. Puigvert, Barcelona, Spain
Hosp. Gral. Univ. Gregorio Maranon, Madrid, Spain
Hosp. Univ. 12 de Octubre, Madrid, Spain
Hosp Virgen de La Victoria, Málaga, Spain
Hosp.Univ.Parc Tauli, Sabadell, Spain
Hosp. Univ. Marques de Valdecilla, Santander, Spain
Hosp. Virgen Del Rocio, Seville, Spain
Hosp. Clinico Univ. de Valencia, Valencia, Spain
St Bartholomews Hospital, London, United Kingdom
Salford Royal Hospital, Salford, United Kingdom
Southampton University Hospital, Southampton, United Kingdom
Lister Hospital, Stevenage, United Kingdom Est. completion Jan 1, 2027
Bladder Cancer
Non-Muscle-Invasive Bladder cancer (NMIBC) tumours often recur despite TransUrethral Resection of Bladder (TURB) and Bac…
Saint-Herblain, France Est. completion Jan 2029